report revenu earn street guidanc
sever quarter mid singl digit cc growth increment rais estim
rais multipl ep peer median bring price target
even adjust higher expect fx headwind manag
rais guidanc beat view conserv put posit
beat
result report cc revenu growth
consensu estim diagnost grew cc street
breast health grew cc street gyn surgic
grew cc street skelet health grew cc
street cynosur declin cc
street estim grown three consecut quarter adjust gross
margin declin due mix tariff macro condit oper margin
grew non-gaap ep street
guidanc manag rais revenu guidanc cc growth
street
rais non-gaap ep low end street
includ cc revenu growth street
non-gaap ep interestingli revenu beat quarterli
guidanc midpoint rais guidanc even
adjust addit fx headwind impli less beat
view guidanc conserv believ strong posit beat
given manag confid underli momentum busi
busi updat out-performance driven molecular diagnost cc
growth third consecut quarter doubl digit growth
difficult comp manag believ molecular grower increas
panther util menu expans lead us believ room upsid
breast health grew cc broad strength believ convers
cycl room run custom remain acquisit faxitron focal
contribut nice quarter manag confid success integr
compani announc acquisit superson imagin potenti add
anoth imag product portfolio remain confid cynosur stabil
bottom line think strong print continu momentum diagnost
breast health posit beat
new product adopt fda regul competit acquisit integr
inc focus provid health care product women
price close juli
ep
debt total capit
ep exclud one-tim item includ sbc
piper jaffray seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis report read conjunct import disclosur inform
includ attest regul analyst certif found page report follow site
page
thousand
provis incom tax
product sale
good sold product sale
compani report piper jaffray co current disclosur inform compani locat
page
